Latest News

Kantsu HD Co.,Ltd. ( TSE:9326 ) announced strong profits, but the stock was stagnant. Our analysis suggests that this...

Investors are often guided by the idea of discovering 'the next big thing', even if that means buying 'story stocks...

Hanking Gold International Limited's ( HKG:3788 ) recent weak earnings report didn't cause a big stock movement...

Just because a business does not make any money, does not mean that the stock will go down. For example, Pure Resources...

Ringer Hut Co.,Ltd. ( TSE:8200 ) announced strong profits, but the stock was stagnant. We did some digging, and we...

It is usually uneventful when a single insider buys stock. However, When quite a few insiders buy shares, as it...

Yamaguchi Financial Group, Inc. ( TSE:8418 ) shareholders will have a reason to smile today, with the analysts making...

China Saftower International Holding Group Limited ( HKG:8623 ) insiders who bought shares over the past year were...

Wondering whether Organon at around US$9.76 is a bargain or a value trap? This article walks you through what the current price might be saying about the stock. The share price has moved sharply in the short term, with returns of 10.5% over 7 days and 56.7% over 30 days. However, it still shows an 11.4% decline over 1 year and a 53.5% decline over 3 years. Recent coverage has focused on Organon as a stand-alone pharmaceutical business following its separation from its former parent, with...

Why Takeda Pharmaceutical (TSE:4502) Is Back on Investor Radars Takeda Pharmaceutical (TSE:4502) has drawn fresh attention after recent share price moves, including a 4.8% decline over the past month and a 10.1% gain over the past three months, prompting closer scrutiny of its fundamentals. See our latest analysis for Takeda Pharmaceutical. The recent pullback, including a 4.8% 1 month share price return and 2.6% 7 day share price return, sits against a stronger backdrop, with a 3 month share...

Earlier this week, Ford Motor Company unveiled a new Product Creation and Industrialization organization that unites its EV, digital, design and global industrial teams, while simultaneously amending several unsecured credit facilities totaling about US$21.00 billion to extend maturities and maintain a minimum US$4.00 billion liquidity covenant. This restructuring not only supports Ford’s Ford+ plan and Universal Electric Vehicle platform ambitions, but also removes sustainability-linked...

Board resignation and pre earnings caution Trade Desk (TTD) heads into its upcoming earnings report under a cautious spotlight, as recent commentary questions whether second half revenue expectations align with fee scrutiny and rising competition from larger tech and AI focused platforms. See our latest analysis for Trade Desk. Trade Desk's US$22.47 share price reflects a sharp reset in expectations, with a 7 day share price return of 11.85% contrasting with a 40.37% year to date share price...

GameStop Corp. recently launched Power Packs, a digital trading card platform that lets collectors buy online packs to unlock real PSA-graded Pokémon, football, basketball, and baseball cards stored in the PSA Vault, with options to sell back instantly, ship, or add to their collection. By pairing digital pack purchases with professionally graded, vault-stored physical cards and instant liquidity, Power Packs pushes GameStop deeper into the emerging digital-to-physical collectibles...

Wondering if Visteon at around US$98.65 is offering real value or just recent excitement? This article walks through what the current share price might be implying about the business. The stock has shown sharp moves recently, with returns of 4.9% over 7 days, 16.8% over 30 days, 1.8% year to date and 38.6% over 1 year, set against weaker 3 year and 5 year returns of 32.3% and 15.6% declines. These mixed time frames suggest sentiment around Visteon has shifted at different points, which can...

Bausch + Lomb recently secured FDA 510(k) clearance for its Bi-Blade+ vitrectomy cutter and Adaptive Fluidics upgrade while launching the enVista Envy intraocular lens in Europe and showcasing an expanded portfolio at the ASCRS 2026 meeting. Together, these advances deepen the company’s presence in premium surgical vision care by emphasizing intraocular pressure stability, surgical efficiency and full-range vision options. We’ll now explore how the Bi-Blade+ and Adaptive Fluidics clearance...

Samsara (IOT) is in focus after International Motors joined its Pre-Delivery Installation program, agreeing to ship new International trucks and IC Bus school buses with Samsara hardware factory-installed across North America. See our latest analysis for Samsara. The International Motors agreement lands as Samsara’s 7 day share price return of 18.45% contrasts with a 30 day share price decline of 9.09% and a 1 year total shareholder return decline of 18.39%, which hints at short term momentum...

Edgewell Personal Care: Recent Returns Put Fresh Focus on the Stock Edgewell Personal Care (EPC) has drawn fresh attention after a strong recent share price move, with the stock up about 4.6% on the day and recording double digit gains over the past month. See our latest analysis for Edgewell Personal Care. That sharp recent move sits on top of a 38.8% year to date share price return, even as the 1 year total shareholder return is about 19.9% lower. This suggests momentum has picked up after...

State Street Q1 2026 earnings at a glance State Street (STT) has opened 2026 with a steady earnings profile, coming off Q4 2025 revenue of US$3.7b and basic EPS of US$2.46, backed by trailing twelve month revenue of US$13.9b and EPS of US$9.55. The company has seen revenue move from US$12.9b in the twelve months to Q4 2024 to US$13.9b in the latest twelve month period, while EPS over the same windows shifted from US$8.34 to US$9.55. This gives a clear sense of how the income statement is...

If you are wondering whether Edwards Lifesciences at around US$80.99 is a fair deal or a stretched price, the starting point is understanding how its current market value stacks up against several valuation checks. The share price has moved 4.0% over the last 7 days, while returns for the past month and year to date sit at 2.0% decline and 5.1% decline. A 13.2% gain over the last year adds an extra layer to the current pricing question. Recent coverage has focused on Edwards Lifesciences as...

Earlier this month, Science Applications International Corp. announced its role as NASA’s mission assurance partner for the completed Artemis II lunar mission, providing safety analysis, risk mitigation tools, and real-time oversight across the Space Launch System, Orion spacecraft, ground systems, and crew survival over the nearly 10‑day journey. The company’s deep integration into Artemis II, from cross-program hazard analysis to post‑flight lessons learned, highlights its embedded...

Badger Meter (BMI) has opened 2026 earnings season with Q1 results that sit against a trailing 12 month backdrop of US$916.7 million in revenue, basic EPS of US$4.82 and net income of US$141.6 million. The most recent reported quarter in 2025 showed revenue of US$220.7 million, basic EPS of US$1.14 and net income of US$33.6 million. Over the past six reported quarters, revenue has moved from US$205.2 million in Q4 2024 to a range between US$222.2 million and US$238.1 million through 2025,...

Alcoa Q1 2026 Earnings Snapshot Alcoa (AA) opened 2026 with Q1 revenue of US$3.2 billion and basic EPS of US$1.61, setting the tone for how the year is starting to shape up against prior performance. Over recent quarters, revenue has moved between US$3.0 billion and US$3.5 billion while quarterly EPS has ranged from roughly US$0.63 to US$2.08, giving investors a clear view of how top line and EPS have tracked together through different pricing and production conditions. With margins backing...

Investors may be wondering whether Williams Companies at around US$71.15 still offers value after a strong run, or if most of the upside is already priced in. The share price has seen a 2.2% decline over the last week and a 2.3% decline over the last month, while returns stand at 16.9% year to date and 25.4% over the last year. Over the past three years the stock has delivered a very large total return, and over five years the gain has also been very large, which frames current moves against...

Bank First (BFC) opened 2026 with Q1 total revenue of US$63.7 million and basic EPS of US$1.78, alongside trailing twelve month revenue of US$193.7 million and EPS of US$7.18 that reflect five year earnings growth of 13.4% per year and 7.1% growth in the most recent year. Over the last few reported periods, revenue has moved from US$41.1 million in Q4 2024 to US$42.7 million in Q1 2025 and US$44.9 million in Q4 2025 before reaching US$63.7 million in Q1 2026, while quarterly EPS has ranged...